Lifshitz & Miller LLP Announces Investigation of Centrue Financial Corporation, Motorola Solutions, Inc., Natus Medical Incorporated, Northern Dynasty Minerals Ltd., Ocera Therapeutics, Inc., Psychemedics Corporation, RH and Stemline Therapeutics, Inc.
NEW YORK, Feb. 17, 2017 /PRNewswire/ --
Centrue Financial Corporation (CFCB)
Lifshitz & Miller announces an investigation into possible breaches of fiduciary duties by the board of directors of CFCB in connection with the sale of CFCB to Midland States Bancorp, Inc. for approximately $26.75 per share.
For more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by sending an e-mail including your contact information to: [email protected].
Motorola Solutions, Inc. (MSI)
Lifshitz & Miller announces investigation on behalf of MSI investors concerning the sustainability of MSI's alleged anti-competitive sales tactics.
If you are an MSI investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].
Natus Medical Incorporated (BABY)
Lifshitz & Miller announces investigation on behalf of BABY investors concerning whether BABY adequately disclosed its inability to enforce a supply contract with the Venezuelan government.
If you are a BABY investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].
Northern Dynasty Minerals Ltd. (NAK)
Lifshitz & Miller announces investigation on behalf of NAK investors concerning whether NAK adequately disclosed the commercial sustainability of the low-grade Pebble deposit.
If you are a NAK investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].
Ocera Therapeutics, Inc. (OCRX)
Lifshitz & Miller announces investigation on behalf of OCRX investors concerning the results of OCRX's phase 2b study of Ornithine Phenylacetate.
If you are an OCRX investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].
Psychemedics Corporation (PMD)
Lifshitz & Miller announces investigation on behalf of PMD investors concerning whether PMD's Brazilian distributor was engaged in illegal anti-competitive practices.
If you are a PMD investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].
RH (RH)
Lifshitz & Miller announces investigation on behalf of RH investors concerning whether RH concealed problems with the launch of the RH Modern product line.
If you are an RH investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].
Stemline Therapeutics, Inc. (STML)
Lifshitz & Miller announces investigation on behalf of STML investors concerning a patient death in STML's BPDCN Trial of cancer drug SL-401.
If you are an STML investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].
ATTORNEY ADVERTISING. © 2017 Lifshitz & Miller LLP. The law firm responsible for this advertisement is Lifshitz & Miller LLP, 821 Franklin Avenue, Suite 209, Garden City, New York 11530, Tel: (516)493-9780. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Contact:
Joshua M. Lifshitz, Esq.
Lifshitz & Miller LLP
Phone: 516-493-9780
Facsimile: 516-280-7376
Email: [email protected]
SOURCE Lifshitz & Miller Law Firm
Share this article